AllergoPharma

Reinbek, Germany Founded: 1969 • Age: 57 yrs Acquired By Dermapharm
Allergen immunotherapies for IgE-mediated diseases are developed by AllergoPharma.
Request Access

About AllergoPharma

AllergoPharma is a company based in Reinbek (Germany) founded in 1969 was acquired by Dermapharm in February 2020.. The company has 5,990 employees as of December 31, 2019. AllergoPharma operates in a competitive market with competitors including BeiGene, Vir Biotechnology, Cidara Therapeutics, BioNTech and Stallergenes Greer, among others.

  • Headquarter Reinbek, Germany
  • Employees 5990 as on 31 Dec, 2019
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Allergopharma India Private Limited
  • Date of Incorporation 02 Feb, 2024
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    5990

    as on Dec 31, 2019

  • Acquired by
    Dermapharm

    (Feb 19, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of AllergoPharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AllergoPharma

AllergoPharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Dermapharm. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Dermatological and pharmaceutical medications are developed and manufactured.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AllergoPharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AllergoPharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Allergopharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AllergoPharma

AllergoPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Vir Biotechnology, Cidara Therapeutics, BioNTech and Stallergenes Greer, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
Developer of therapeutics for the treatment of infectious diseases
domain founded_year HQ Location
Novel anti-infectives for bacterial and fungal infections are developed.
domain founded_year HQ Location
Immunotherapeutics for cancer and other diseases are developed.
domain founded_year HQ Location
Allergen immunotherapies for respiratory allergies are developed.
domain founded_year HQ Location
Medicines are developed to protect, repair, and restore hearing capacity.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Allergopharma

Frequently Asked Questions about AllergoPharma

When was AllergoPharma founded?

AllergoPharma was founded in 1969.

Where is AllergoPharma located?

AllergoPharma is headquartered in Reinbek, Germany. It is registered at Reinbek, Schleswig-holstein, Germany.

How many employees does AllergoPharma have?

As of Dec 31, 2019, the latest employee count at AllergoPharma is 5,990.

What does AllergoPharma do?

AllergoPharma was founded in 1969 in Reinbek, Germany, as a specialty pharmaceutical company focused on allergen immunotherapies. As a subsidiary of Merck, causal treatments for IgE-mediated allergic diseases are developed, including subcutaneous options for unavoidable allergens such as pollen and dust mites. Operations center on advancing therapies for respiratory and other allergies in the European market.

Who are the top competitors of AllergoPharma?

AllergoPharma's top competitors include BeiGene, BioNTech and Decibel Therapeutics.

Who are AllergoPharma's investors?

AllergoPharma has 1 investor. Key investors include Dermapharm.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available